Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

News Daily News

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

Michael O'Riordan

October 18, 2016

News Conference News ESC 2016

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

Michael O'Riordan

August 28, 2016

News Daily News

MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer

Michael H. Wilson

July 13, 2016

News Daily News

With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year

Michael H. Wilson

June 28, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

L.A. McKeown

May 24, 2016

News Daily News

Comparative Analysis Suggests ACE Inhibitors Equivalent to ARBs in Patients Without Heart Failure

Michael O'Riordan

January 19, 2016

News Daily News

比较分析表明无心衰患者使用 ACE 抑制剂和 ARB 类药物效果相当

Michael O'Riordan

January 19, 2016

News Daily News

Un Análisis Comparativo Sugiere que los Inhibidores de la ECA Equivalen a los ARB en Pacientes Sin Insuficiencia Cardíaca

Michael O'Riordan

January 19, 2016

News Industry News

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

August 31, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Daily News

Heart Failure Still a Problem but Less of a Burden on Acute MI Patients

Todd Neale

March 11, 2015

Advertisement

AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications

ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH

MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer

With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

Comparative Analysis Suggests ACE Inhibitors Equivalent to ARBs in Patients Without Heart Failure

比较分析表明无心衰患者使用 ACE 抑制剂和 ARB 类药物效果相当

Un Análisis Comparativo Sugiere que los Inhibidores de la ECA Equivalen a los ARB en Pacientes Sin Insuficiencia Cardíaca

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

Heart Failure Still a Problem but Less of a Burden on Acute MI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content